These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32978310)

  • 21. Impact of COVID-19 on tuberculosis services in India.
    Gupta A; Singla R; Caminero JA; Singla N; Mrigpuri P; Mohan A
    Int J Tuberc Lung Dis; 2020 Jun; 24(6):637-639. PubMed ID: 32553014
    [No Abstract]   [Full Text] [Related]  

  • 22. Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China.
    Chen H; Zhang K
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32703778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?
    Sands P
    Lancet Glob Health; 2020 Sep; 8(9):e1102-e1103. PubMed ID: 32673576
    [No Abstract]   [Full Text] [Related]  

  • 24. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and Tuberculosis: A Meeting of Two Pandemics!
    Gupta U; Prakash A; Sachdeva S; Pangtey GS; Khosla A; Aggarwal R; Sud R; Margekar SL
    J Assoc Physicians India; 2020 Dec; 68(12):69-72. PubMed ID: 33247647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 and TB control in immigrant communities.
    Wilson FA; Miller TL; Stimpson JP
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):975-977. PubMed ID: 33156769
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy.
    Magro P; Formenti B; Marchese V; Gulletta M; Tomasoni LR; Caligaris S; Castelli F; Matteelli A
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celebrating World Tuberculosis Day at the time of COVID-19.
    Alagna R; Besozzi G; Codecasa LR; Gori A; Migliori GB; Raviglione M; Cirillo DM
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32241828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The COVID-19 pandemic and the true incidence of Tuberculosis in Japan.
    Komiya K; Yamasue M; Takahashi O; Hiramatsu K; Kadota JI; Kato S
    J Infect; 2020 Sep; 81(3):e24-e25. PubMed ID: 32650109
    [No Abstract]   [Full Text] [Related]  

  • 30. Lessons From Tuberculosis Control for COVID-19: Screening Should Be Universal.
    Thébaud-Mony A; Turshen TBM
    New Solut; 2020 Nov; 30(3):168-172. PubMed ID: 32903152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The (in)significance of TB and COVID-19 co-infection.
    Khurana AK; Aggarwal D
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32554537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis in the time of COVID-19: quality of life and digital innovation.
    Visca D; Tiberi S; Pontali E; Spanevello A; Migliori GB
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32513783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The COVID-19 pandemic and tuberculosis in Taiwan.
    Lai CC; Yu WL
    J Infect; 2020 Aug; 81(2):e159-e161. PubMed ID: 32534000
    [No Abstract]   [Full Text] [Related]  

  • 34. Learning from tuberculosis: COVID-19 highlights the need for more robust infection control policy.
    Moran A; Mphahlele M; Mvusi L; Dlamini C; Ahmedov S; AlMossawi HJ; Kak N
    J Glob Health; 2020 Dec; 10(2):020328. PubMed ID: 33110528
    [No Abstract]   [Full Text] [Related]  

  • 35. Adapting TB services during the COVID-19 pandemic in Mumbai, India.
    Meneguim AC; Rebello L; Das M; Ravi S; Mathur T; Mankar S; Kharate S; Tipre P; Oswal V; Iyer A; Mansoor H; Kalon S; Garone D; Ferlazzo G; Isaakidis P
    Int J Tuberc Lung Dis; 2020 Oct; 24(10):1119-1121. PubMed ID: 33126951
    [No Abstract]   [Full Text] [Related]  

  • 36. New diseases and old threats: lessons from tuberculosis for the COVID-19 response.
    Dara M; Sotgiu G; Reichler MR; Chiang CY; Chee CBE; Migliori GB
    Int J Tuberc Lung Dis; 2020 May; 24(5):544-545. PubMed ID: 32398212
    [No Abstract]   [Full Text] [Related]  

  • 37. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapting a TB contact investigation strategy for COVID-19.
    Nguyen TA; Cuong QN; Kim ALT; Huong TN; Nguyen HN; Fox GJ; Marks GB
    Int J Tuberc Lung Dis; 2020 May; 24(5):548-550. PubMed ID: 32398215
    [No Abstract]   [Full Text] [Related]  

  • 39. Maintaining robust HIV and tuberculosis services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Mukwenha S; Dzinamarira T; Mugurungi O; Musuka G
    Int J Infect Dis; 2020 Nov; 100():394-395. PubMed ID: 32979586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis control and care in the era of COVID-19.
    Malik AA; Safdar N; Chandir S; Khan U; Khowaja S; Riaz N; Maniar R; Jaswal M; Khan AJ; Hussain H
    Health Policy Plan; 2020 Oct; 35(8):1130-1132. PubMed ID: 32832996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.